| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
| Pulse Biosciences, Inc Common Stock (DE) | $1.3b | $23.05 | +0.2% | 37.0K | |
| Arbutus Biopharma Corporation Common Stock | $0.8b | $4.53 | +1.0% | 285.5K | |
| Rani Therapeutics Holdings, Inc. Class A Common Stock | $76.1m | $0.85 | +1.0% | 468.4K | |
| Clene Inc. Common Stock | $56.8m | $5.96 | +16.3% | 141.9K | |
| Zentek Ltd. Common Stock | $55.4m | $0.55 | +3.7% | 25.8K | |
| Lexaria Bioscience Corp. Common Stock | $19.4m | $1.04 | +0.5% | 245.2K | |
| NanoViricides Inc. | $18.8m | $1.02 | +10.2% | 124.0K | |
| Polyrizon Ltd. Ordinary Shares | $12.4m | $12.03 | -0.4% | 28.8K | |
| TransCode Therapeutics, Inc. Common Stock | $7.9m | $8.81 | +2.5% | 594 | |
| Aspire Biopharma Holdings, Inc. Common Stock | $4.8m | $1.09 | +6.5% | 38.1K |